Transcript Bio-Economy Strategy - Amazon Web Services

The National
BIO-ECONOMY STRATEGY
A Bio-economy
"Bioeconomy" refers to activities that make use of
bioinnovations, based on biological sources, materials
and processes to generate sustainable economic,
social and environmental development.
• Allows SA to respond more directly to global challenges such as the
disease burden, food security, competitive industry, climate change
and energy requirements.
• Provide an engine for future growth
• Science-based "biosolutions" can be used to, e.g.
– manufacture high-value protein products - biopharmaceuticals /
vaccines;
– produce biofuels;
– improve and adapt crops;
– remedy industrial and municipal waste;
2
Timeline
Nat Biotech
Strategy
2001
2009 Outputs:
•14 platforms established
•73 projects funded
•Investment into 31 companies
•221 products & 142 services
Instruments:
BRICs; NBN;
PUB 2003
•940 jobs
•439 bursaries/indirect study support
•R247 mill leveraged (on R1 bill)
Bioeconomy
5% of GDP
2050
Incorporation
of ‘learnings’
Merge into
TIA 2009
Bio-economy
Strategy
development
2009-2013
Functioning
NSI 2020
3
CONTEXT: Key features of
SA Bio-economy’s NSI
• Highly complex system (multiple technologies; value chains;
approaches; role-players; service providers; highly regulated)
• No single outcome (agriculture; health; industry / biocontrol;
bioproducts; biomanufacturing / goods; services; processes / new-to-market
goods; replacement goods; green goods)
• Limited local market & highly competitive globally
• No large biotech companies / R&D branches to
acquire spin-offs / locally-developed technologies
• Fragmentation in SA NSI
• Insufficient Industry/govt pull & market relevance
4
Challenges/opportunities
•
Large but under-employed rural communities
•
High burden of disease, excellence in R&D, but underinvestment in innovation opportunities
•
Increasing global food quality standards
•
Under-utilised – but substantial - livestock populations
•
Need for continual improvement of commercially-relevant
plants & animals
•
Need to revitalise certain labour-intensive industries to
maintain global competitiveness – eg. sugar; forestry
•
Carbon footprint / green economy
•
•
Commercialise& mainstream IKS biodiversity products
Climate Change
5
Bioeconomy Strategy
Phytotherapies and pharma production
Health:
Biological and
chemical APIs,
biosimilars,
Vaccines, New
therapies,
diagnostics
Biodiversity:
Plants, microbes,
marine resources
•
Large Basic Research
Capacity and skills
development
•
Technology platforms and
Centres of Competence
•
Pre-commercial
infrastructure
•
IP management strategies
•
Legislation and demand
support policies
•
Appropriate Financing
•
Internationalisation
•
Biosafety
•
Fine Chemical production
Biomass feedstock
Animal and plant therapeutics and diagnostics
Primary production:
Crops, fibre, livestock
Industry:
Biofuels, bioplastics,
bioproducts, unique
enzymes
6
Adapted OECD, 2009. The Bioeconomy to 2030: Designing a Policy Agenda, Paris: Organisation for Economic Cooperation and Development
Linked to other policies
7
Roles of departments
8
Different roles of stakeholders
9
Full value chain
Concept
Research
Manufacturing
Productisation
Commercialisation
Development
© 2012 DNAbiotec®
10
Enablers & cross-cutters
Human
Capital
World-class
research
standards
Next
generation
technologies
Leadership
framework
National
priorities
Communication
and marketing
Ethical
framework
Close gaps in
Innovation
Cycle
Access global
IP & knowledge
pools
Align
regulations
Incentives and
funding
11
Role of DST
• Coordination leadership
•
•
•
•
•
•
Coordinating Committees (Govt; Industry; S.Councils; Academia
– strategic guidance)
Coordination of projects across value chain (networking of, &
value-addition to, projects)
Orchestration of RDI innovators (incl. Technology Platforms;
Team SA)
Alignment of RD&I with industry and govt. needs
Review roles of role-players
DST as a service dept.
• Develop strategic innovation competencies.
• Develop strategic innovation programmes to
address strategic gaps or opportunities for the
country.
12
Role of DST (2)
• Coordinate stakeholders and role players.
• Develop strategic innovation competencies.
– Development of the full value chain from concept to product.
– Bioinformatics, functional genomics, structural biology, synthetic
biology and systems biology. [Bio-design]
– Technology service platforms. [TIA platforms]
– Pilot-scale infrastructure. [Bio-processing plant ]
– Incubation facilities. [Bio-technology parks]
– Financing. [Grants / venture capital]
– Human capital development [incl Entrepreneurial skills]
– Instruments to address specific knowledge needs. [e.g
Biosafety]
– Knowledge management to develop a bioportal.
• Develop strategic innovation programmes to address
strategic gaps or opportunities for the country.
13
Role of DST
• Coordinate stakeholders and role players.
• Develop strategic innovation competencies.
• Develop strategic innovation programmes to
address strategic gaps or opportunities for the
country.
14
Agricultural sector
• Network of agro-innovation hubs
• Strategic projects
– Crop/livestock improvement both for biotic and physical stresses associated with
climate change (including indigenous crops)
– Agroprocessing initiatives
– An integrated food nutrition research programme
– Animal vaccine capabilities
– Energy-crop initiatives
– Biocontrol and biofertilisers
– Aquaculture
– Soil conservation
– Water resource management
15
Health
• Develop improved drugs to address priority diseases (incl. African
Traditional Medicine);
• Develop new and improved vaccines and biologics;
• Develop improved diagnostics;
• Develop improved medical devices;
• Strengthen clinical research and development capabilities;
• Establish pharmaceutical manufacturing.
16
Health
17
Health (African Traditional Medicine)
18
Industrial and environmental sector
Industrial applications
Biobased
chemicals
Biomaterials
Bulk and
speciality
chemicals
Sustainable Environmental
Management
Bioenergy
Biodiesel
Biocatalysts
Biocomposites
Bioethanol
Biocontrol
products
Biopolymers
Biobutanol
Biogas
Water
Bioremediation
of domestic and
industrial
wastewater
Waste
Bioleaching
Biometallurgy
Biosorption
Additives
Enabling technologies
Synthetic and structural biology
Functional genomics
19
Industrial & environmental
•
•
•
•
•
•
•
Strategic industrial biotechnology programmes
Biomanufacturing capacity and capabilities
Local bioprocessing capabilities
Integrated biorefineries
Wastewater R&D
Solid waste R&D
Utilise enabling and emerging technologies
20
Indicators (to be informed by study)
Bioeconomy
HCD
R&D
Commercialisation
Coordination
Bioeconomy
contribution to GDP
Student outputs per
year
No. of publications
and citations in highimpact journals per
capita.
No. of products and
services
No. of collaborative
research
partnerships
Technology balance
of payment of bioinnovation outputs.
Throughput of nonacademic skills
training (incl.
entrepreneurialism)
Cumulative no. of biopatents / plant
breeders rights
No. of start up
companies
No of companies
reaching break even
No. of
collaborativeproduc
t development
partnerships
No.of bio-innovation
firms, including
dedicated bioinnovation firms by
sector
Size of bioworkforce as
percentage of S&T
workforce.
No.of regulatory
approvals for locally
produced
health/agricultural
products.
No. multinational
corporations in bioeconomy sectors
locating R & D
facilities locally
No. of funding
partnerships
Leveraging
international
resources
No. of projects
progressing
between funding
institutions
No. of regulatory
approvals for locally
produced
health/agricultural
products.
21
Next steps
• Appoint coordinating committees
• Development of coordinated and costed implementation
plans, across the value chain:
 Health Innovation
 Agriculture and primary production bio-innovation
 Industrial and environmental bio-innovation
with focus on priority areas and cross-cutting issues such
as infrastructure, funding, human capital development
• Development of a knowledge management system
(Bioportal)
• Development of a monitoring and evaluation system
(indicators)
22
Thank you!
23